Biography

Dr Hafid Soualhine obtained his PhD in 2001 on molecular mechanism of drug resistance in Mycobacterium tuberculosis, and did postdoctoral fellowship at Laval University-QC and at UBC - BC on bacterial genomics and recombinant TB vaccines. He worked at McGill University and chief of Mycobacteriology Reference lab in Quebec. Now at the National Reference Centre for Mycobacteriology- NML, He is leading TB omics implementation, technology transfer to provincial laboratories, and collaboration with international consortiums on innovative bioinformatics pipelines for TB and NMT. He is also managing mycobacterial research projects on AMR, NTM and TB surveillance using innovative omics technologies

Expertise

TB Diagnostics
Public Health

Key Impacts

Molecular subspeciation and antimicrobial resistance prediction in M. avium complex by whole genome sequencing

Our MAC genomics works has demonstrated potential of WGS for identification and subspeciation of MAC, a concordance between WGS-based AMR prediction and phenotypic DST for macrolide but not for aminoglycosides and quinolones

Source: Conference 2024